DISCOVERYBIOMED INC has a total of 34 patent applications. Its first patent ever was published in 2009. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and measurement are CANCER THERAPEUTICS CRC PTY LTD, COVEX SA and AlzeCure Pharma AB.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 7 | |
#2 | Canada | 5 | |
#3 | EPO (European Patent Office) | 5 | |
#4 | United States | 5 | |
#5 | Australia | 4 | |
#6 | China | 2 | |
#7 | Hong Kong | 2 | |
#8 | Republic of Korea | 2 | |
#9 | Mexico | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Measurement | |
#4 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Analysing materials | |
#5 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Schwiebert Erik | 29 |
#2 | Dixon John | 28 |
#3 | Streiff John | 28 |
#4 | Gao Hongwu | 27 |
#5 | Mai Deborah | 10 |
#6 | Ritchie Joseph P | 9 |
#7 | Seales Eric C | 9 |
#8 | Schwiebert Erik M | 3 |
#9 | Bebok Zsuzsa | 3 |
#10 | Collawn James F | 3 |
Publication | Filing date | Title |
---|---|---|
WO2020243360A1 | Human diseased and normal kidney epithelial cell cultures and uses thereof | |
CN105246887A | Coumarin derivatives and methods of use in treating hyperproliferative diseases | |
EP2970248A2 | Coumarin derivatives and methods of use in treating cystic fibrosis, chronic obstructive pulmonary disease, and misfolded protein disorders | |
WO2014081821A2 | Small Molecule Bicyclic and Tricyclic CFTR Correctors | |
WO2014081820A1 | Small molecule cftr correctors | |
WO2012158913A2 | Treating protein folding disorders with small molecule cftr correctors | |
WO2010111653A2 | Modulating ires-mediated translation |